Kidney Transplantation Clinical Trial
Official title:
Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors. Comparison of the Taking of Kidney by cœliosurgery (Pure or " Hand-assisted "), by cœliosurgery Assisted by Robot and by the Classic Technique of Open Donor Nephrectomy.
The main objective of this multicentre study is to conduct the evaluation of cost-efficiency
of various techniques of kidney taking with regard the quality of life of the kidney living
donors.
It will allow to compare three techniques of taking (open donor nephrectomy, cœliosurgery
pure or " hand-assisted " and cœliosurgery assisted by robot) and to determine their
respective advantages in quality of life, then their medico-economic consequences in a
cost-efficiency approach from the point of view of the society.
The evaluation will concern the donor and the receiver followed three months after the
taking.
The open donor nephrectomy will be the technique of reference with which will be compared
the two others.
Context : The most efficient treatment of the terminal chronic renal insufficiency is the
renal transplantation, but in spite of the realization of more than 2000 transplants a year
in France, the waiting list increases every year in a important way. The decrease of the
offer of transplants from deathly donors led numerous countries to develop the renal
transplant from alive donors. This type of transplantation represents in 2007 only 8,1 % of
transplants in France (report of ABM on 2007), but the deficit in renal transplants and the
new laws of bioethics should increase this donation (it represents until 70 % of the renal
transplantations in certain centres of North America or the Northern Europe).
Although the French urology is at the top of the laparoscopic technique, the classic
surgical taking by lombotomie stays the reference technique, practised by 58 % of the
centres, with for the patient its consequences in terms of pain, of duration of
hospitalization, convalescence and possible side effects. The development of the taking by
cœliosurgery, mini-invasive technique, allowed to increase the number of wishes of organ
donation in the centres which developed it. It is however a difficult technical gesture,
requiring an important experience. This technique has the inconvenience of a more painful
scar and more subject to complications than the section known pubic of "Pfannenstiel" used
for the taking by pure cœliosurgery.
The surgical robot Da Vinci (Intuitive Surgical, Sunnyvale, California), with a 3D mink, the
joints of the instruments inside the body, the reduction of the movements, the best
ergonomics, improves the precision of the cœlioscopic gesture, but has a sharply upper cost.
The CHU of Nancy was the pioneer in Europe to develop this technique from 2002, with very
encouraging results on a series from now on more than 80 patients.
Only retrospective studies compared the quality of life between these techniques, and in
spite of the major financial impacts (10 years of dialysis represent 100 K€; the price of
the robot is of 1700 K€) and the important differences of quality of life according to these
various surgical approaches, no prospective comparative medico-economic study was realized
up to now. In France, where the hospital bears the load of all the expenses concerning the
donor, including its daily allowances during its medical certificate, the shortening of the
hospitalization and of the convalescence of the donor as well as the results improved by the
transplantation at the receiver of a kidney living donor would allow a fast amortization of
these expensive technologies.
Main objective : To compare the cost and the efficiency of the three techniques of taking of
kidney living donor.
Main assessment criterion : The quality of life of the donor tested by generic measuring
instruments EUROQOL and SF-36 (both to D-1 (the day before the renal transplantation), D4 (4
days after) and D90 (3 months after) and SF-36 to D-1 and D90). It will be realized at the
donor's in preoperative (D-1), in postoperative (D4) and in the visit of follow-up in 3
months (D90). It will be also collected at the receiver's in preoperative (D-1),
postoperative immediate (D4) and in the visit of follow-up in 3 months (D90).
The combination with the cost estimate will allow to build the marginal cost-efficiency
ratio.
Secondary objectives envisaged:
- The evaluation of the quality of life of the receiver by measuring instrument becomes
generic EUROQOL and SF-36 to D-1, D4 (only Euroqol) and D90.
- The comparison of the comfort of the surgeon and his physical and psychic investment by
index card(form) of specific evaluation (Borg and NASA-TLX).
- The comparison of the coelio-surgical techniques : pure coelioscopy, coelioscopy "
hand-assisted " and coelioscopy assisted by robot will concern the quality of life and
the marginal cost-efficiency ratio.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT02723591 -
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
|
Phase 4 | |
Completed |
NCT05945511 -
Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
|
||
Completed |
NCT02234349 -
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Not yet recruiting |
NCT05934383 -
Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT04936971 -
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
|
Phase 4 | |
Not yet recruiting |
NCT04540640 -
Oxygenated Machine Preservation in Kidney Transplantation
|
N/A | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Recruiting |
NCT02908139 -
Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients
|
N/A | |
Terminated |
NCT02417870 -
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02560558 -
Bela 8 Week Dosing
|
Phase 4 | |
Recruiting |
NCT02154815 -
Pre-emptive Kidney Transplantation Quality of Life
|
N/A | |
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Enrolling by invitation |
NCT01905514 -
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
|
N/A | |
Completed |
NCT02147210 -
Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
|
N/A | |
Recruiting |
NCT01699360 -
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
|
Phase 4 | |
Terminated |
NCT01436305 -
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
|
Phase 2 | |
Completed |
NCT01655563 -
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
|
Phase 2 |